An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia

BACKGROUND: The artemisinin-based combination treatment (ACT) of dihydroartemisinin (DHA) and piperaquine (PQP) is a promising novel anti-malarial drug effective against multi-drug resistant falciparum malaria. The aim of this study was to show non-inferiority of DHA/PQP vs. artesunate-mefloquine (A...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Valecha, Neena, Phyo, Aung Pyae, Mayxay, Mayfong, Newton, Paul N., Krudsood, Srivicha, Keomany, Sommay, Khanthavong, Maniphone, Pongvongsa, Tiengkham, Ruangveerayuth, Ronnatrai, Uthaisil, Chirapong, Ubben, David, Duparc, Stephan, Bacchieri, Antonella, Corsi, Marco, Rao, Bappanad H. K., Bhattacharya, Prabash C., Dubhashi, Nagesh, Ghosh, Susanta K., Dev, Vas, Kumar, Ashwani, Pukittayakamee, Sasithon
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2010
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2912766/
https://ncbi.nlm.nih.gov/pubmed/20689583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0011880
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars